09:52 AM EST - Kane Biotech Inc. : announced that the Corporation has entered into an agreement to: (a) extend the maturity date of its previously issued $500,000 principal amount two-year 10% convertible redeemable unsecured note from December 18, 2015 to June 18, 2017; and (b) change the price at which such Note may be convertible into common shares of the Corporation from $0.15 per Common Share to $0.10 per Common Share. Kane Biotech Inc.
shares V.KNE are trading unchanged at $0.05.
